Meiji Seika Of Japan Launches Antidepressant Mirtazapine
This article was originally published in PharmAsia News
Executive Summary
Japanese food and drug conglomerate Meiji Seika launched Sept. 7 Reflex (mirtazapine), a noradrenergic and specific serotonergic antidepressant